Author: Elodie Nguyen

Health Tech Spotlight: Laura Yecies – CEO at Bone Health Technologies

CEO Laura Yecies is interviewed about how their easy-to-use medical device can prevent osteoporosis, winning the One Harvard New Venture Competition, and playing the violin!


“In terms of research funding, we have nothing to complain about — we have benefited from very generous grants — and what I find in my fundraising (is) if it’s a male audience where they don’t have a lot of domain expertise, they don’t get it,” Yecies said. “But it resonates with women, and I am getting more interest from women investors, angel investors and VC firms led by women.”

ViewPoints Interview: BoneHealth Technologies’ Laura Yecies Shares Insights on OsteoBoost Vibration Belt

In a recent interview with PharmaShots, Laura Yecies, CEO of BoneHealth Technologies shared her views on OsteoBoost Vibration Belt that has been granted “Breakthrough Device” designation by the US FDA.

FDA breakthrough device designation strengthens Osteoboost outlook

Bone Health Technologies Inc. may be on the verge of upstaging a common drug therapy, but don’t tell them to break a leg. The San Francisco-based company’s Osteoboost Vibration Belt received a U.S. FDA breakthrough designation for technology that delivers gentle stimulation to reduce bone loss and prevent osteoporosis with the goal of reducing the number of potentially devastating broken bones in the elderly.

Osteoporosis Prevention Product Wins FDA Breakthrough Device Designation

Bone Health Technologies, creator of the OsteoBoost Vibration Belt that promises to reduce the risk of osteoporosis, has been granted “Breakthrough Device” designation by the US Food & Drug Administration.